Forecast: Chronic Obstructive Pulmonary Diseases Mortality in the US

The mortality rate for Chronic Obstructive Pulmonary Disease (COPD) among men in the US displayed a mixed pattern from 2013 to 2023, reaching 43.9 deaths per hundred thousand men in 2023. The year-on-year variations show fluctuations, with notable decreases in 2014, 2019, and 2020, while increases were observed in 2015, 2016, and 2017. The Compound Annual Growth Rate (CAGR) over the past five years (2019-2023) stands at -0.8%, indicating a slight decline in the mortality rate.

Looking ahead, the forecasted data suggest a gradual increase in the mortality rate from 2024 to 2028, with a projected rate of 44.7 deaths per hundred thousand men by 2028. The average annual trend over the next five years (2023-2028) is expected to have a 0.32% CAGR and an overall growth of 1.59%.

Future trends to watch for include advances in medical treatments, public health initiatives targeting risk factors, shifts in smoking rates, and environmental policy changes aimed at reducing respiratory risks, which could influence the long-term trajectory of COPD mortality rates.

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease